COMP <GO>
NDSN vs BRK-A // EV/EBITDA & P/E VALUATION
Nordson Corporation (NASDAQ) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: NDSN 3
— BRK-A 9
▲ EV/EBITDA & P/E VALUATION LEADER: BRK-A
LAST: $329.10 (+0.95%) • MKT CAP: $18.33B
valuation
26.5x
LAST: $817,500.00 (+0.68%) • MKT CAP: $1.20T
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NDSN VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NDSN | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.40% | 11.47% | -0.07 | BRK-A | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 26.5x | 9.7x | +16.82 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 3.61% | 2.09% | +1.52 | NDSN | /fcf-yield <GO> |
| Operating Margin | 25.50% | 27.80% | -2.30 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 22.30% | -4.90 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 3.80% | 3.93% | -0.13 | BRK-A | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.98% | 0.00% | +0.98 | NDSN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | NDSN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 68.1 | -13.40 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.13 | -0.22 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.2x | 24.3x | +10.86 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.33B | $1.20T | -$1.18T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NDSN REV | BRK-A REV | NDSN GROSS % | BRK-A GROSS % | NDSN FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.79B | $247.24B | 55.2% | — | $661.1M | $25.04B |
| FY 2024 | $2.69B | $249.71B | 55.2% | — | $491.8M | $11.62B |
| FY 2023 | $2.63B | $254.91B | — | — | $523.0M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NDSN // BETA 0.91
BRK-A // BETA 1.13